Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_assertion type Assertion NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_head.
- NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_assertion description "[These data showed that circulating Tg mRNA is not only a more sensitive marker of residual thyroid tissue or thyroid cancer than sTg, particularly in patients during T4 therapy and with positive antithyroglobulin antibodies, but also was more sensitive than NIS mRNA in all patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_provenance.
- NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_assertion evidence source_evidence_literature NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_provenance.
- NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_assertion SIO_000772 11061512 NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_provenance.
- NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_assertion wasDerivedFrom befree-20140225 NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_provenance.
- NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_assertion wasGeneratedBy ECO_0000203 NP250336.RAh8m45nNy8b1XBEDNZlFakC4QRcVo0-F8AMV50U2EQng130_provenance.